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   Experimental models are used for understanding pathogenesis of disease, evaluating the pharmaceutical 
efficacy and developing therapeutics for the human body. This experimental research can be achieved by means 
of in vitro and in vivo models. Thus, the appropriate experimental in vivo and in vitro models are important for the 
human disease related studies. In vivo animal models address a variety of scientific questions of disease, from 
basic science to the elucidation of pathological mechanism, and prevention or therapeutic strategies. The use of 
mice as in vivo models for human disease is not only based on the genetic and physiological similarities between 
the species, but also being able to mimic any human disease or condition by genetic engineering. In vitro model 
has many advantages with comparison to in vivo model, such as precise control of chemical and physical 
environment, decrease in animal numbers, lower expense on animal maintenance and care and shorter time period 
with higher throughput. Mammalian cell in vitro model provides a defined platform for investigation of cell biology, 
development of tissue engineering, understanding of the pathological underlying mechanisms of diseases and 
cellular drug response. However, the results obtained from in vitro models have often failed to adequately represent 
the in vivo situation, resulting in discrepancy between the in vitro and in vivo studies. The typical culture system 
on petri dishes and tissue culture flasks receives completely different environments compared to those in a natural 
tissue nanoenvironment. These differences induce the alterations in cell morphology, responses and functions, 
resulting in failing to reflect in vivo cell behavior. If the natural nanoenvironment could be mimicked by 
nanopattern use for in vitro model, it could bridge the discrepancy between in vivo and in vitro models  
   Inflammatory bowel disease (IBD) is a chronic, remitting and relapsing inflammatory disease of the 
gastrointestinal tract characterized by inflammation and mucosal tissue damage and is associated with significant 
morbidity. Ulcerative colitis and Crohn’s disease are the two most common forms of IBD. Ulcerative colitis and 
Crohn’s disease differ from each other in physiology but show similar symptoms such as severe diarrhea, rectal 
bleeding, abdominal pain, fever, and weight loss. Clinical and epidemiological evidence suggests that IBD is a 
systemic disorder that can affect almost every organ. Renal manifestations and complications in patients with IBD 
are not rare, and numerous clinical studies have reported that 4–23% of IBD patients experience renal disease such 
as tubulointerstitial nephritis, nephrolithiasis, and glomerulonephritis, which eventually induce renal disease. The 
appropriate experimental animal model of IBD-associated renal disease thus has clinical importance for related 
studies, including pathological mechanisms, prevention and treatment strategies for IBD. 
   In this dissertation, it was hypothesized that mimicking the natural nanoenvironment by nanopattern could 
bridge the discrepancy between in vivo and in vitro models. To examine my hypothesis, both in vivo model by 
dextran sulfate sodium (DSS)-colitis mice model and in vitro diseased model by disease-mimic nanopattern were 
established to induce the cellular responses mimicking the renal disease condition. This dissertation has achieved 
1) investigated the glomerular structural change in the experimental mice with DSS-induced colitis, 2) evaluated 
the effects of disease-mimic nanopattern on mesangial cells (MCs) proliferation and matrix change, and 3) 
evaluated the effect of TGF-𝛽1 on diseased mimic nanopattern for establishing the drug screening platform. This 
dissertation consists of five chapters. 
   Chapter I is the introduction of this dissertation, and it presents the advantages of experimental in vivo and in 
vitro models and its importance in the human diseases related studies. The discrepancy between in vivo and in vitro 
model due to the difference in the natural nanoenvironment is also provided. In addition, this chapter introduces 
the solution for reducing the discrepancy between in vitro to in vivo research. Then, this chapter explains my 
hypothesis and purpose. 
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   Chapter II presents the aim to investigate the glomerular structural change in the experimental mice with 
dextran sulfate sodium (DSS)-induced colitis. Firstly, the background of IBD and its effect on other organs due to 
systemic inflammation are reviewed. In addition, this chapter introduces IBD patients’ experience of renal disease, 
which can lead to the progression of kidney injury and fibrosis, and it eventually could induce kidney failure. 
Furthermore, damage of glomerular function due to the reduced glomerular filtration rate (GFR) in IBD patients 
is also mentioned. However, because of lacking funding for glomerular structure change, which is important for 
the filtration function of kidney. Herein, this chapter focuses on DSS induced renal structural changes, particularly 
to the glomerular structure. Experimental IBD was induced by administering 3.5% DSS in Slc:ICR strain mice for 
eight days. Histological changes to colon and glomeruli were examined by periodic acid-Schiff (PAS) and 
Masson’s trichrome staining. Expressions of glomerular collagens were analyzed by immunofluorescent staining 
and Western blot analysis. Expressions of inflammatory cytokines, interlukin-6 (IL-6), tumor necrosis factor-alpha 
(TNF-α) and transforming growth factor beta-1 (TGF-β1) were analyzed by Western blot analysis. The results 
showed an elevated disease activity index (DAI), colon shortening, massive cellular infiltration and colon damage 
with inflammatory cell infiltration were also detected in mice after DSS administration, confirming that DSS-
colitis mice can be used as an IBD animal model. In addition, DSS-colitis mice showed increased glycoprotein 
and collagen deposition in glomeruli. Interestingly, significant changes in glomerular collagens, including a 
decrease in type IV collagen, and an increase in type I collagen were observed. Moreover, higher expression of 
proinflammatory cytokines, IL-6, TNF-α and TGF-β1 were also detected in renal cortex. These results were not 
only consistent with the clinical reports in IBD patients but also mention that glomerular structure change is related 
to glomerular collagen change, suggesting this in vivo model could be useful for the study of IBD-associated renal 
disease. 
   Chapter III presents that development of an in vitro renal disease model to study the influence on mesangial 
cell behavior. In this chapter, three different fibril-forming nanopatterns mimicking the diseased mesangial matrix 
(MM) were designed for disease-mimic. In addition, one network-forming nanopattern mimicking the normal MM 
was designed for normal-mimic, and an unpatterned flat control was also used. Normal mouse mesangial cell line 
SV40MES13 (MES13) was used to evaluate cell morphology, cell proliferation, extracellular matrix (ECM) 
synthesis change and expressions of ECM synthesis related proteins after 24 h or 48 h of seeding on 
TiO2 nanopatterns. The staining of F-actin filaments by rhodamine-conjugated phalloidin revealed F80/200 
nanopattern induced MES13 cell to present fusiform and elongated morphology. The altered morphology of MCs 
could affect cell functions such as cell adhesion, proliferation and MM component secretion. The results of cell 
proliferation determined by 5-ethynyl-2′-deoxyuridine (EdU) proliferation assays showed a significant increase in 
cells cultured on disease-mimic nanopatterns, including F80/80, F80/200 and F200/80. In addition, the highest 
proliferation was showed in cells cultured on the F80/200 nanopattern. Aberrant MC proliferation in mesangium 
is commonly observed in patients with glomerular disease. Increased type I collagen and fibronectin expressions 
were detected in cells cultured on the F80/80, F200/80 and particularly the F80/200 nanopattern. Moreover, higher 
TGF-β1 expression was detected in the cell leading edge when grown on the F80/200 nanopattern compared to the 
other nanopatterns, revealing that the F80/200 nanopattern-induced ECM component change could be mediated 
by TGF-β1. The results indicated that disease-mimic nanopattern induced cell morphological change, proliferation 
and matrix change. In contrast, the normal-mimic nanopattern actually resulted in cells displaying normal 
proliferation and the production of normal MM components. These results were consistent with the in vivo animal 
model, which I established previously. These results bring the conclusion that the disease-mimic nanopattern 
induced disease-like cell behavior and normal-mimic nanopattern induced normal-like cell behavior. 
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   Chapter IV presents that evaluation of physical and chemical cues on disease-mimic nanopattern as a drug 
screening platform. For drug discovery process, the screening of libraries containing hundreds of thousands of 
compounds requires screening by the disease-mimic platform. Thus, disease-mimic model is necessary. This 
chapter aimed to evaluate the effect of TGF-𝛽1 on diseased mimic nanopattern for establishing the drug screening 
platform. Development of a new drug screening platform using disease-mimic condition including chemical cue 
and physical cue was evaluated by diseased matrix components synthesis. Model drugs were used to determine 
whether the disease-mimic condition could be controlled. Normal mouse mesangial cell line MES13 was used to 
investigate type I collagen synthesis change after treated by 1 ng/mL TGF-𝛽1 on each nanopattern for 48 h. 
Dexamethasone (DEX, a steroid anti-inflammatotory drug, 10 nM) and A83-01 (TGF-	𝛽1 inhibitor, 1µM) were 
used as modelling drugs. Results showed slightly increased type I collagen expression was detected in cells 
cultured on disease-mimic nanopattern (F80/200) without TGF-𝛽1, whereas no obvious type I collagen expression 
in cell cultured on normal-mimic nanopattern and flat control. After treating with TGF-𝛽1, significantly increased 
type I collagen was detected in cells cultured on disease-mimic nanopattern. In contrast, slightly increased type I 
collagen were detected in cells cultured on normal-mimic and flat-control. However, significantly decreased type 
I collagen was detected in cells cultured on disease-mimic nanopattern after co-treating with TGF-𝛽1+A83-01 and 
TGF-𝛽1+DEX, even lower than disease-mimic nanopattern induced type I collagen expression (without TGF-𝛽1). 
An appropriate biomarker is also an important part for screening platform. Reactive oxygen species (ROS) plays 
an important role in the modulation of inflammation-related factor production of cellular oxidative metabolism in 
kidney injury. ROS production was investigated in cells after treating with 1 ng/mL TGF-𝛽1 on each nanopattern 
for 12 h by staining with CellROX fluorogenic probe. Results showed slightly increased ROS production was 
detected in cells cultured on disease-mimic nanopattern without TGF-𝛽1, whereas no obvious ROS induction in 
cell cultured on normal-mimic nanopattern and flat control. After treating with TGF-𝛽1, significantly increased 
ROS production was detected in cells cultured on disease-mimic nanopattern. In contrast, slightly increased ROS 
production was detected in cells cultured on normal-mimic and flat-control. In addition, significantly decreased 
ROS production was detected in cells cultured on disease-mimic nanopattern after co-treating with TGF-𝛽1+ A83-
01 and TGF-𝛽1+DEX, even lower than disease-mimic nanopattern induced ROS production (without TGF-𝛽1). 
This chapter indicates that TGF-𝛽1 (chemical cue) and disease mimic nanopattern (physical cue) enhanced type I 
collagen expression and ROS production in cell. Model drugs, A83-01 and DEX, decreased type I collagen 
expression and ROS production in cells by physical and chemical cues. Therefore, this in vitro model could be 
used as a drug screening platform and ROS could be the biomarker for this disease-mimic model.  
   Chapter V describes the achievement, discussion, conclusions and future perspectives of this dissertation. 
Based on the results that 1) In vivo DSS-colitis mice model showed consistent results with clinical reports of IBD 
patients, and 2) In vitro model using disease-mimic nanopattern showed consistent results with DSS-colitis mice 
model, these findings could support my hypothesis that “Mimicking the natural nanoenvironment by nanopattern 
bridges the discrepancy between in vivo and in vitro models”. In addition, this in vitro culture using disease-mimic 
physical and chemical cues could be used as a drug screening platform. Finally, this work might be applied to other 
organ-specific disease-mimic systems after the adjustment of the parameters according to organ-specific 
nanostructure and to establish the organ-specific in vitro fibrosis model. 
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